Evidence map›Paper›PMID 35763033›Full record

ArticleExperimental brain research2022

Inhibitory framing in hypersexual patients with Parkinson's disease. An fMRI pilot study.

Hendrik Theis, Catharina Probst, Anna Campabadal, Katharina S Goerlich, Oliver Granert, Stephan Wolff, Karsten Witt, Günther Deuschl, Thilo van Eimeren

Open access · hybridAbstract read
In one paragraph

Article in Experimental brain research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Dopamine system involvement in impulse control.Experimental brain research · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Hendrik TheisFaculty of Medicine, Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
Catharina ProbstFaculty of Medicine, Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
Anna CampabadalFaculty of Medicine, Medical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Katharina S GoerlichDepartment of Biomedical Sciences of Cells & Systems, Section Cognitive Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Oliver GranertFaculty of Medicine, Department of Neurology, University of Kiel, Kiel, Germany.
Stephan WolffFaculty of Medicine, Department of Radiology, University of Kiel, Kiel, Germany.
Karsten WittCarl von Ossietzky-University, Department of Neurology, Evangelical Hospital Oldenburg and Research Center of Neurosensory Sciences, Oldenburg, Germany.
Günther DeuschlFaculty of Medicine, Department of Neurology, University of Kiel, Kiel, Germany.
Thilo van EimerenFaculty of Medicine, Department of Nuclear Medicine, University of Cologne, Cologne, Germany. thilo.van-eimeren@uk-koeln.de.ORCID http://orcid.org/0000-0002-6951-2325
Christian-Albrechts-Universität zu Kiel · DEUniversity of Cologne · DECarl von Ossietzky Universität Oldenburg · DETH Köln - University of Applied Sciences · DEUniversitat de Barcelona · ESUniversity Medical Center Groningen · NL

Funding

Deutsche Forschungsgemeinschaft 249777455Deutsche Forschungsgemeinschaft 431549029
6 · The paper itself

Abstract

Hypersexuality in medicated patients with PD is caused by an increased influence of motivational drive areas and a decreased influence of inhibitory control areas due to dopaminergic medication. In this pilot study, we test a newly developed paradigm investigating the influence of dopaminergic medication on brain activation elicited by sexual pictures with and without inhibitory contextual framing. Twenty PD patients with and without hypersexuality were examined with fMRI either OFF or ON standardized dopaminergic medication. The paradigm consisted of a priming phase where either a neutral context or an inhibitory context was presented. This priming phase was either followed by a sexual or a neutral target. Sexual, compared to neutral pictures resulted in a BOLD activation of various brain regions implicated in sexual processing. Hypersexual PD patients showed increased activity compared to PD controls in these regions. There was no relevant effect of medication between the two groups. The inhibitory context elicited less activation in inhibition-related areas in hypersexual PD, but had no influence on the perception of sexual cues. The paradigm partially worked: reactivity of motivational brain areas to sexual cues was increased in hypersexual PD and inhibitory contextual framing lead to decreased activation of inhibitory control areas in PD. We could not find a medication effect and the length of the inhibitory stimulus was not optimal to suppress reactivity to sexual cues. Our data provide new insights into the mechanisms of hypersexuality and warrant a replication with a greater cohort and an optimized stimulus length in the future.

Indexed as

Parkinson DiseaseDopamine AgentsHumansMagnetic Resonance ImagingPilot ProjectsSexual BehaviorDopamine AgentsAddictionDopamineFunctional MRIImpulse control

Identifiers

PMID35763033
PMCPMC9288360
OpenAlexW4283654729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.